Summit Therapeutics, Inc. Logo

Summit Therapeutics, Inc.

Senior Analyst

Posted 17 Days Ago
Be an Early Applicant
Remote
Hiring Remotely in USA
117K-130K Annually
Senior level
Remote
Hiring Remotely in USA
117K-130K Annually
Senior level
Support SEC reporting and month-end close by preparing schedules for Form 10-Q/10-K and proxy, performing tie-outs, tracking clinical trial and research-related expenses and vendor accruals, preparing and posting journal entries and accruals, responding to auditor requests, participating in financial system improvements, and supporting ad hoc accounting projects.
The summary above was generated by AI

About Summit:

Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit’s core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence.

Summit’s team is inspired to touch and help change lives through Summit’s clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including:

Non-small Cell Lung Cancer (NSCLC)

  • HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI.

  • HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC.

  • HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC.

Colorectal Cancer (CRC)

  • HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy.

Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland.

Overview of Role: 

Reporting to the Director of SEC Reporting, the Senior Analyst will be an integral member of the Accounting team. This role will be focused on assisting with SEC reporting and month-end close activities. 


Role and Responsibilities: 

  • Assist with the preparation of supporting schedules for form 10-Q, 10-K, and proxy 
  • Perform tie out of form 10-K and 10-Q 
  • Assist with tracking and recording clinical trial and research-related expenses, including vendor accruals and study-related costs 
  • Prepare and post journal entries, including accruals and other standard closing entries 
  • Assist with internal and external auditor requests 
  • Participate in process improvements, financial system implementations and/or enhancements 
  • Assist with ad hoc projects as needed 
  • All other duties as assigned 

 

Experience, Education and Specialized Knowledge and Skills: 

  • Minimum bachelor's degree in accounting 
  • Minimum 4+ years of experience in accounting 
  • Results-oriented, strong organizational skills, and time management skills with ability to multi-task 
  • A team player willing to step in and help with other areas of accounting 
  • Excellent analytical, interpersonal, verbal, and written communication skills 
  • Superb analytical, strategic, and critical thinking skills, with impeccable attention to detail, and strong prioritization and problem-solving skills 
  • Demonstrated ability to operate in a fast-paced environment 
  • Attention to detail, accuracy and confidentiality 
  • Excellent organizational, management, analytical & decision-making skills 
  • An ability to work well cross functionally and across geographies 
  • Impeccable integrity and a strong work ethic 

This is the pay for this position

Pay Transparency
$117,000$130,000 USD

Actual compensation packages are based on several factors that are unique to each candidate, including but not limited to skill set, depth of experience, certifications, and specific work location. This may be different in other locations due to differences in the cost of labor. The total compensation package for this position may also include bonus, stock, benefits and/or other applicable variable compensation.

Summit does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact Summit’s Talent Acquisition team at [email protected] to obtain prior written authorization before referring any candidates to Summit.

Summit Therapeutics Inc. is an Equal Opportunity Employer and takes pride in creating and maintaining diverse environment. We do not discriminate in recruitment, hiring, training or promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status.

Similar Jobs

2 Hours Ago
Remote or Hybrid
80K-108K Annually
Senior level
80K-108K Annually
Senior level
Cloud • Fintech • Software • Business Intelligence • Consulting • Financial Services
Lead financial modeling, valuation, and due diligence for M&A deals; prepare deal materials and executive presentations; coordinate transactions from discovery through definitive agreements; collaborate with internal teams and communicate deal structure and rationale to targets and leadership.
Top Skills: ExcelOutlookPowerPointVirtual Data Room (Vdr)Word
Yesterday
Remote or Hybrid
73K-130K Annually
Senior level
73K-130K Annually
Senior level
Artificial Intelligence • Big Data • Healthtech • Information Technology • Machine Learning • Software • Analytics
Lead Medicaid pricing analysis and actuarial modeling to optimize revenue for Community & State business. Analyze state rate files, claims, forecasts, and trends, support product development, competitive analysis, and process automation while working cross-functionally with internal and external actuarial stakeholders.
Top Skills: ExcelSASSnowflakeSQL
2 Days Ago
In-Office or Remote
106K-125K Annually
Senior level
106K-125K Annually
Senior level
Fintech
Serve as primary triage owner for escalated production defects across Investment Platform products. Troubleshoot using logs, SQL, monitoring and session-replay tools, determine root cause, classify issues, write requirements and acceptance criteria, coordinate fixes with developers/QA/product, manage backlog prioritization, document investigations and drive preventive improvements to reduce repeat incidents.
Top Skills: Ai-Enabled ToolsAzure DevopsDatadogFullstoryJIRAMongoDBSalesforceSQL

What you need to know about the Seattle Tech Scene

Home to tech titans like Microsoft and Amazon, Seattle punches far above its weight in innovation. But its surrounding mountains, sprinkled with world-famous hiking trails and climbing routes, make the city a destination for outdoorsy types as well. Established as a logging town before shifting to shipbuilding and logistics, the Emerald City is now known for its contributions to aerospace, software, biotech and cloud computing. And its status as a thriving tech ecosystem is attracting out-of-town companies looking to establish new tech and engineering hubs.

Key Facts About Seattle Tech

  • Number of Tech Workers: 287,000; 13% of overall workforce (2024 CompTIA survey)
  • Major Tech Employers: Amazon, Microsoft, Meta, Google
  • Key Industries: Artificial intelligence, cloud computing, software, biotechnology, game development
  • Funding Landscape: $3.1 billion in venture capital funding in 2024 (Pitchbook)
  • Notable Investors: Madrona, Fuse, Tola, Maveron
  • Research Centers and Universities: University of Washington, Seattle University, Seattle Pacific University, Allen Institute for Brain Science, Bill & Melinda Gates Foundation, Seattle Children’s Research Institute

Sign up now Access later

Create Free Account

Please log in or sign up to report this job.

Create Free Account